Search results
Please enter search term
Slaughter and May, Hong Kong, advised Wing Tai Properties on a property joint venture with Manhattan Garments
Slaughter and May, Hong Kong, advised Wing Tai Properties on a property joint venture with Manhattan Garments
Slaughter and May is advising GlaxoSmithKline on the creation of a world-leading Consumer Healthcare joint venture with Pfizer
Slaughter and May is advising GlaxoSmithKline on the creation of a world-leading Consumer Healthcare joint venture with Pfizer
Slaughter and May advised HomeServe plc on its issue of US private placement notes
HomeServe plc on its issue of US private placement notes
Slaughter and May advised Alibaba on its cornerstone investment in Fosun Tourism
Slaughter and May advised Alibaba on its cornerstone investment in Fosun Tourism
Slaughter and May has advised Swire Pacific Limited on the sale of its paints business
Swire Pacific Limited on the sale of its paints business
Slaughter and May is advising Alibaba on its acquisition of shares in Alibaba Pictures
Alibaba on its acquisition of shares in Alibaba Pictures
Slaughter and May advised YTL Corporation Berhad on the acquisition of the entire issued share capital of a Spanish project company
Slaughter and May advised YTL Corporation Berhad on the acquisition of the entire issued share capital of a Spanish project company
Slaughter and May has advised on the first dual primary listing in HK of an Australian company - Yancoal Australia Ltd
First dual primary listing in HK of an Australian company - Yancoal Australia Ltd
Slaughter and May is advising GlaxoSmithKline on the divestment of Horlicks and other consumer healthcare nutrition brands to Unilever
Slaughter and May is advising GlaxoSmithKline on the divestment of Horlicks and other consumer healthcare nutrition brands to Unilever
Slaughter and May advised Derwent London plc - note purchase agreement for the issue and purchase of £250 million private placement notes
Derwent London plc - note purchase agreement for the issue and purchase of £250 million private placement notes